These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


291 related items for PubMed ID: 10661388

  • 1. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8).
    Newton JR, Townsend HG, Wood JL, Sinclair R, Hannant D, Mumford JA.
    Equine Vet J; 2000 Jan; 32(1):65-74. PubMed ID: 10661388
    [Abstract] [Full Text] [Related]

  • 2. Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).
    Mumford J, Wood JM, Scott AM, Folkers C, Schild GC.
    J Hyg (Lond); 1983 Jun; 90(3):385-95. PubMed ID: 6306098
    [Abstract] [Full Text] [Related]

  • 3. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
    Daly JM, Yates PJ, Newton JR, Park A, Henley W, Wood JL, Davis-Poynter N, Mumford JA.
    Vaccine; 2004 Sep 28; 22(29-30):4101-9. PubMed ID: 15364463
    [Abstract] [Full Text] [Related]

  • 4. Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus.
    Mumford JA, Wood JM, Folkers C, Schild GC.
    Epidemiol Infect; 1988 Jun 28; 100(3):501-10. PubMed ID: 2837409
    [Abstract] [Full Text] [Related]

  • 5. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease.
    Newton JR, Daly JM, Spencer L, Mumford JA.
    Vet Rec; 2006 Feb 11; 158(6):185-92. PubMed ID: 16474051
    [Abstract] [Full Text] [Related]

  • 6. A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus.
    Gildea S, Arkins S, Cullinane A.
    Influenza Other Respir Viruses; 2010 Nov 11; 4(6):363-72. PubMed ID: 20958930
    [Abstract] [Full Text] [Related]

  • 7. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.
    Paillot R, Prowse L, Montesso F, Huang CM, Barnes H, Escala J.
    Vet Microbiol; 2013 Mar 23; 162(2-4):396-407. PubMed ID: 23146168
    [Abstract] [Full Text] [Related]

  • 8. The outbreak of equine influenza (H3N8) in the United Kingdom in 1989: diagnostic use of an antigen capture ELISA.
    Livesay GJ, O'Neill T, Hannant D, Yadav MP, Mumford JA.
    Vet Rec; 1993 Nov 20; 133(21):515-9. PubMed ID: 8310627
    [Abstract] [Full Text] [Related]

  • 9. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R, Grimmett H, Elton D, Daly JM.
    Vet Res; 2008 Nov 20; 39(3):21. PubMed ID: 18252187
    [Abstract] [Full Text] [Related]

  • 10. Use of a blocking ELISA for antibodies to equine influenza virus as a test to distinguish between naturally infected and vaccinated horses: proof of concept studies.
    Kirkland PD, Delbridge G.
    Aust Vet J; 2011 Jul 20; 89 Suppl 1():45-6. PubMed ID: 21711288
    [Abstract] [Full Text] [Related]

  • 11. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short-term vaccine efficacy study.
    Daly JM, Sindle T, Tearle J, Barquero N, Newton JR, Corning S.
    Equine Vet J; 2007 Sep 20; 39(5):446-50. PubMed ID: 17910270
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
    Paillot R, Prowse L, Donald C, Medcalf E, Montesso F, Bryant N, Watson J, Jeggo M, Elton D, Newton R, Trail P, Barnes H.
    Vet Immunol Immunopathol; 2010 Aug 15; 136(3-4):272-83. PubMed ID: 20400185
    [Abstract] [Full Text] [Related]

  • 13. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination.
    Soboll G, Hussey SB, Minke JM, Landolt GA, Hunter JS, Jagannatha S, Lunn DP.
    Vet Immunol Immunopathol; 2010 May 15; 135(1-2):100-107. PubMed ID: 20018384
    [Abstract] [Full Text] [Related]

  • 14. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
    Paillot R, Kydd JH, Sindle T, Hannant D, Edlund Toulemonde C, Audonnet JC, Minke JM, Daly JM.
    Vet Immunol Immunopathol; 2006 Aug 15; 112(3-4):225-33. PubMed ID: 16621023
    [Abstract] [Full Text] [Related]

  • 15. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.
    Gildea S, Arkins S, Walsh C, Cullinane A.
    Vaccine; 2011 Nov 15; 29(49):9214-23. PubMed ID: 21983355
    [Abstract] [Full Text] [Related]

  • 16. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF, Daly J, Hannant D, Wilkins J, Francis MJ.
    Vaccine; 2004 Dec 02; 23(3):418-25. PubMed ID: 15530689
    [Abstract] [Full Text] [Related]

  • 17. The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA).
    Galvin P, Gildea S, Arkins S, Walsh C, Cullinane A.
    Influenza Other Respir Viruses; 2013 Dec 02; 7 Suppl 4(Suppl 4):73-80. PubMed ID: 24224822
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic methods applied to analysis of an outbreak of equine influenza in a riding school in which vaccine failure occurred.
    van Maanen C, van Essen GJ, Minke J, Daly JM, Yates PJ.
    Vet Microbiol; 2003 Jun 10; 93(4):291-306. PubMed ID: 12713892
    [Abstract] [Full Text] [Related]

  • 19. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
    Lopez AM, Hecker R, Mutwiri G, van Drunen Littel-van den Hurk S, Babiuk LA, Townsend HG.
    Vet Immunol Immunopathol; 2006 Nov 15; 114(1-2):103-10. PubMed ID: 16950519
    [Abstract] [Full Text] [Related]

  • 20. Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach.
    Gildea S, Sanchez Higgins MJ, Johnson G, Walsh C, Cullinane A.
    Influenza Other Respir Viruses; 2016 Sep 15; 10(5):433-7. PubMed ID: 27169603
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.